MAPT and Alzheimer disease: Strikingly, US-BBBD alone has been shown to reduce β-amyloid and tau pathologies, stimulate neurogenesis, and improve cognitive performance in mouse AD models [16–18] and can be further coupled with drug therapies to improve their brain penetration and efficacy [13, 19, 20].